Introduction
Measurement of the immediate psychological responses to methylamphetamine may provide a way of studying central catecholaminergic neurotransmission in depressed patients. In animals (C. J. Estler, 1975) and presumably in Man as well (Johnsson et al, 1971 ) the behavioural effects of amphetamines are prob ably mediated by increases in the concen trations of noradrenaline and dopamine at central receptor sites. Drugs which block the synthesis of these catecholamines inhibit the behaviouraleffectsof amphetamines in a variety of animal species (Weissman et al, 1966) including Man (Johnsson eta!, 1971 cases of depressive illness then amphetamines should exert an anti-depressant action whose time course is related to that of the changes in concentrations of noradrenaline at central receptor sites. As these concentrations rise the depressions should be alleviated and as they fall the depressions should return.
To follow the time course of any anti depressant effect of amphetamines it is necessary to consider the other effects of amphetamines. Intravenous injection of an amphetamine frequently causes an initial feeling of drowsiness which is often associated with physical symp toms of autonomic origin (Levine at a!, 1948; Liddell and Weil-Malherbe, 1953; Simon and Taube, 1946) . Many subjects then experience a feeling of alertness, notice they are talking more and describe changes of mood (Lasagna et al, 1955; Martin et a!, 1971; Nathanson, 1937; Smith and Beecher, 1960) . Both patients and normal subjects frequently describe an euphoria which is described as a pleasant feeling of well being and an increased self-confidence. The characteristic symptoms of hypomania are not produced although if they are already present theymay be either exacerbated, (Delay,1949) , or relieved (Von Beckmann and Heinemann, 1976) . Some normal subjects experience dys phoric symptoms which include both anxiety and sadness (von Felsinger at a!, 1955) . In some cases the whole experience may be dominated either by an abreaction (Jonas, 1954; Liddell and Weil-Malherbe, 1953) or, in some psychotic patients, by the exaggeration of previously held delusional ideas (Myerson, 1936; Pennes, 1954) .
In this report the immediate psychological responses to methylamphetamine and placebo are compared in a group of depressed patients and in a group of patients with other psychiatric illnesses. The prediction is made that an anti depressant response will be seen during the first hour after injection of the drug, at the time when a rise in the concentration of noradrenaline at central receptor sites is most likely.
Methods
The selection of the depressedpatients has been described previously (Checkley and Crammer, 1977) . Depressed patients met strin gent drug-free and diagnostic criteria. The severity and type of the depressive illnesses were recorded using the Hamilton Rating Scale (Hamilton, 1967) and the Carney Roth Garside Questionnaire (Carney et al, 1965) . Depressed patients with other diagnoses such as personality disorder, alcoholism or dementia were excluded, as were patients with medical illnesses.
A control group was composed ofin-patients at the same hospital who met the same drug free criteria. This group included patients with psychiatric illnesses other than depressive states orfunctional ororganic psychoses.
The rating scales
A series of 16 scales (Norris, 1971) has been found to be suitable for measuring the short term effects of drugs upon mood in normal subjects (Bond and Lader, 1974) . This can be shortened to three visual analogue mood scales, â€˜¿ which are labelled alert-drowsy, happy-sad and calm-excited. These were used every 15 minutes up to 60 minutes after injection of methyl amphetamine. A shortened and modified form of the Hamilton Rating Scale for use in depression was administered2@ hours afterthe injection of methylamphetamine.
The symptoms labelled depressed mood, guilt, suicide, retardation, agitation, psychic anxiety, somatic anxiety, hypochondriasis and insight, were rated accord ing to Hamilton's (1967) definitions but with the modification that symptoms were only rated if they were present during the previous hour. The other items in the Hamilton Rating Scale which cover symptoms such as insomnia, diurnal variation and weight loss were rejected as they cannot be rated in the same way. The full Hamilton Rating Scale for use in depression, and the Carney Roth Garside questionnaire, were administered 14 hours before adminis tration of the drug.
The experi mental procedure
Patients were given a standardized explana tion of the research nature of the procedure and ofits likely psychological effects. (â€˜You may fora short while feel more happy or more sad, more anxious or more relaxed, or you may notice nothing at all. Any effects you do notice will wear off completely by the end of the test, which can be stopped if you become upset.') Experi ence confirmed that this was a realistic account ofthelikely effects, providedthatpatients with delusional ideas were excluded from study. All patients gave informed consent. On the day of testing patients were fasted from lunch (12.30 p.m.). Rating scales were adminis tered to depressed patients at 4.00 p.m. A small cannula was inserted into a forearm vein at 5.00 p.m. and five minutes later a placebo injection was given. After a further 30 minutes patients received methylamphetamine (15 mg/ 75 kgm body weight) by an intravenous injection which was given over 60 seconds.
The analogue scales labelled alert-drowsy, calm-excited and happy-sad were administered at 0, 15, 30, 45, 60, 75 and 90 minutes after injection of the placebo. They were completed independently both by the patient and by the author. The procedure took place in familiar surroundings in the presence of a nurse who already knew the patient. The shortened version of the Hamilton Rating Scale was administered 14 hours before the injection of methylampheta mine and 2@hours after the injection.
Results

Twenty-two
patients met all the criteria and agreed to participate in the study. Five were unable to complete all of the ratings as they became disturbed after receiving the drug.Two ofthesepatients heldparanoidideas and a third was the only patient in the series who showed an abreaction. Four other patients were too retarded to be able to complete the visual analogue scales every 15 minutes. The remaining 13 patients formed the depressed group whose immediate mood responses could be studied. Ten were women. The group had a mean age of 50 years and a range from 28 to 75. The mean score on the full Hamilton Rating Scale was 23.6 and the range was from 16 to 35. The diagnostic scores derived from the Carney Roth Garside questionnaire all fell within the endogenous range of 6â€"13.Three patients met Perris' (1975) criteria for diagnosing bipolar affective illness and 8 patients met his criteria for the diagnosis of unipolar depressive illness. The median number of previous episodes was 9 (range 0â€"75)and the median duration of the history of treated affective illness was 8 years (range 0â€"21years). Eight of the patients with recurrent illness had received a comprehensive range of physical treatments (Shaw, 1977 ) which had made little or no impact upon the severity of each episode.
The control group included patients with hospital diagnoses of personality disorder (3 cases), obsessive compulsive neurosis (3 cases) and phobic neurosis, Gilles de la Tourette syndrome, and the Klein Levin syndrome (one case each). The control group included 2 women and had a mean ageof26.7 (range17â€"34).
The immediate mood responses
The mood responses of the 13 depressed patients and the 9 control patients are shown in Fig 1. Responses along the alert-drowsy dimension are not shown as the mean values remained unchanged throughout the procedure. To obtain a combined measure of the reliability and validity of the measures, individual responses were measured as the maximum recorded change over the first 30 minutes after administration of the drug. The responses as rated by patient and observer were ranked for each group along each dimension. Spearman rank order correlation co-efficients between the ratings made by patients and the observer varied between 0.4 to 0.7. It can be seen from Fig 1 that there is considerable variation in the responses within each group whether these are measured by the patients or by the observer. Indeed so great was this variation that sig nificant drug effects were only detected in a multivariate analysis of variance with repeated measures, ifthe analysis was arbitrarily restricted to the first 30-minute period after admiis tration of the drug. A detailed examination of the patients' own descriptions of their experi ences will explain the source of this variation.
The responses of the psychotic patients will be discussed first as they show the greatest variation. Four of the 13 depressed patients held delusional ideas asratedon theHamiltonRating Scale. The two patients with delusional ideas of guilt expressed these ideas with increased force throughout the experiment. One asked to be killed and the other wept for 20 minutes while distressed by her ideas of guilt. Both patients rated their mood as happy, saying that they did not deserve to feel sad. Two depressed patients with delusional ideas of bodily change did not become distressed: one described an euphoric reaction and the other showed little response at all. Less variability was noted in the experiences ofpatients who were notpsychotic.
The controls gave straightforward accounts of euphoric experiencesâ€"'I feel great, fantastic, calm'. â€˜¿ I feel like someone who has discovered the Amazon'. â€˜¿ I feel like shouting â€˜¿ yipee'. I could go into a party and chat up all the birds'. The non-psychotic depressed patients gave three types of description. Some patients gave qualified descriptions of euphoric experiences â€˜¿ I feel a little happy.. . I hope I am going to feel happy . . . I don't feel happy any more'. â€˜¿ I feel happy but I wouldn't if you left the room'.
Other depressed patients described feeling more sad and anxious. â€˜¿ Is it my fault? I feel frightened'. â€˜¿ I feel frightened but of nothing in particular'.
A third group of de pressed patients described little change in their mood: two of them were unaware that they had received the drug. No depressed patient described a complete loss of depressive symptoms during the first hour after receiving methyl amphetamine.
Delayed eflÃ¨cts of methylamphetamine
The delayed effects of methylamphetamine could be studied in all 22 depressed patients. Fig 2 shows scores on the shortened and modified Hamilton Rating Scale made at 4.00 p.m., 14 hours before the drug was given, an4 at 8.00 p.m. 24 hours after the drug was given. Fio1.â€"Mean scores (Â±SEM) onvisual analogue mood scales labelled excited-calm (above) andhappy-sad (below) after intravenous injection of placebo at â€"¿ 30 minutes and methylamphetamine (15 mg/75 kgm body weight) at 0 minutes, in patients with endogenous depression (â€˜depressed')and in control patients with other diagnoses (â€˜not depressed'). Self-ratings are shown (0â€"â€"â€"â€" -0) and observer ratings (0 @O).
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Happy @. becomes greater when the residual scores of the 8 patients showing the anti-depressant response are examined. Two patients had scores of 5: both had delusional ideas which persisted after the resolution of all other depressive symptoms. The remaining patients in the group had scores of 24 points or less, which were always due to symptoms of anxiety. No patient in this group was left with any scores for the items labelled depression, guilt, suicide, retardation, agitation or hypochondriasis and none became euphoric or hypomanic.
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The anti-depressant responses came on rapidly 1â€"24 hours after receiving the drug. In six patients the depressions returned the next morning either on waking (at the normal time) or shortly thereafter.
In one patient, the depression returned 18 hours later and in another it returned 36 hours later.
In three of the patients showing an anti depressant response to methylamphetamine it has been possible to repeat the procedure under identical drug-free conditions. One patient showed the anti-depressant response on the second occasion but not on the first, while the othertwo showed iton thefirst occasion but not on the second. No differences were found between the patients who showed an anti-depressant response and those who did not when they were com pared for age, sex, length of history, total or individual scores on the Carney Roth Garside questionnaire or Hamilton Rating Score, nor when they were classified into having unipolar or bipolar illnesses (Perris, 1975) . Control patients did not show any delayed psychological effects of methylamphetamine.
Discussion
The aim of this study was to measure the immediate psychological responses to methyl amphetamine in patients with depressive illness. The noradrenaline depletion hypothesis predicts that there will be an immediate alleviation of depression as a result of an immediate rise in the concentration of noradrenaline at central re ceptor sites. Little immediate alleviation of depression was detected in the patients' des criptions of their mood or in the ratings of mood by patients and observer using visual analogue scales. Yet over the first hour after the injection 26â€"
â€˜¿ ./ 4 pm 8pm Time The responses fell into two groups. In 14 patients the scores changed by three points or less, while in the remaining 8 patients the scores changed by 9 points or more. The significance of this grouping of the responses ofmethylamphetaminean immediaterelease of growth hormone and corticosteroids was meas ured in these patients (Checkley and Crammer, 1977) and in some patients an immediate dysphoric response was noted. As both the hormonal and the psychological responses are probably mediated by central catecholamines (Estler, 1975; Johnsson et a!, 1971; Rees et a!, 1970) ,it is likely that in thesepatients the injection of methylamphetamine caused an immediate rise in the concentrations of cate cholamines at central receptor sites. The finding that there was no simultaneous alle viation of depression suggests that depression is not due to a simple deficiency of central noradrenaline.
The finding that there was a delayed anti depressant response also questions the simple noradrenaline depletion hypothesis. However, the same finding suggests that some disturbance in catecholamine function must be related to the pathogenesis of depression. For a massive stimulus to catecholamine systems can reverse depressive symptoms, aftera delay of several hours.This delay raisesthe possibility that post-synaptic events may intervene between changes in concentrations of catecholamines at receptors and subsequent changes in mood.
It isalsoof interest thatthe anti-depressant response appears to be complete or nearly complete. The main exception to this is that patients do sometimes retain delusional ideas after the loss of their other depressive symptoms. However, this phenomenon is also seen after ECT, and was, in fact, noted in two of the patients in the present series during earlier depressive episodes. The only other symptom which remained was some anxiety which itself could have been a drug effect. With the exception of these two groups of symptoms the anti-depressant reponses seen in these patients were complete. Such a sudden and striking loss of depressive symptoms is reminiscent of the behavioural switch which has been described in patients with cyclical manic-depressive ill nesses (Murphy and Goodwin, 1972; Stoddard et a!, 1977) . A somewhat similar behavioural switch has also been observed after giving L-DOPA (Goodwin et a!, 1970) which itself stimulates catecholamine function, (Pelton and Chase, 1975) .
As thisis the first attempt to measure the immediate psychological effects of the parenteral administration of an amphetamine in psych iatric patients, the present report is concerned with methodological issues. The main difficulty is a conceptualone. Although mood scales labelled alert-drowsy, happy-sad and calm excited are useful for describing normal mood (Bond and Lader, 1974) and for measuring effects of tranquillizers (Bond and Lader, 1973) , they have serious limitations when used for measuring effects of amphetamines.
The re sponses described in the present study, like the responses described by Lasagna in normal subjects (Lasagna et a!, 1955) fall into two categories which may conveniently be labelled as euphoria and dysphoria. These drug-induced mood states are not conveniently measured by analogue scales labelled happy-sad, calm excited or alert-drowsy. The dysphoric reactions contain variable elements of sadness and anxiety while the euphoric reactions include some alertness and some relaxation as well as a striking euphoria. The alert-drowsy dimension is especially confusingas many patients des cribed feeling both alert and drowsy, either in rapid succession or, paradoxically, at the same time. Severely depressed patients are known to have difficulty rating their own mood and it may be necessary to rely mainly upon ratings made by observers. The present study also demonstrates the unwanted variation that can be introduced by the inclusion of psychotic patients. Abreactions would raise similar issues but were infrequent in the present series, possibly because the dose of methylamphetamine (15mg/75 Kgm body weight) was small.
These considerations indicate more sophisti cated ways of measuring the psychological responses to methylamphetamine.
It may be more useful to administer check lists of euphoric and dysphoric symptoms. Preliminary obser vations suggest that such symptoms can be reliably rated in depressed and recovered patients by independent psychiatrists (Checkley, Cookson and Mikhail, unpublished data) .
Finally, it is surprising that the present distinction between the time course of the 245â€"58. euphoric and the anti@depressant' response to amphetamines has not been made in earlier studies of the effects of amphetamines upon depressive illness (Gottlieb et a!, 1950; Kiloh at a!, 1974; Roberts, 1959; Rudolf, 1956; Van Kammen and Murphy, 1975) . It is possible that some of the unusual conditions of the present study highlighted the distinction between the euphoric and the anti-depressant responses. The patients in the present study were selected from many hospitals in order to meet strict criteria, both for the diagnosis of endogenous depression and forexclusion ofdelayedeffects of psychotropic drugs. The experiments were performed later in the day than in the previous studies at a time of spontaneous alleviation of mood, and at a time which approached that of the spontaneous switch mechanism (which is usually seen in the early hours of the morning). Finally, the earlier studies did not closely follow the time course of any drug effects either because the drug was administered orally (van Kammen and Murphy, 1975) or because mood was rated at hourly intervals after administra tion of the drug (Kiloh at al, 1974) . Although the issues raised in this discussion are of general importance, it must be empha sized that the present findings are of a pre liminary nature. As no delayed anti-depressant response was anticipated, an appropriately timed placebo control was not included in the experimental design. It seems unlikely, how ever, that the anti-depressant responses were a placebo effect. They were unexpected by both the patients and the observer, and they occurred in patients who were unresponsive to conven tional anti-depressant treatments. Even so, an appropriately time placebo control is required which will also provide control for any diurnal variation in mood. A replication study with these modificatiÃ ns is in progress. For the moment it would be unwise to assume â€˜¿ that the anti-depressant and the euphoric effects of methylamphetamine are mediated by the same neurochemical events.
